Edgewise Therapeutics Inc (EWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 104,916 | 0 | 0 | 0 |
| Marketable Securities | 24,178 | 0 | 0 | 0 |
| TOTAL | $129,645 | $0 | $0 | $0 |
| Non-Current Assets | ||||
| PPE Net | 516 | N/A | N/A | N/A |
| Other Non-Current Assets | 975 | 0 | 0 | 0 |
| TOTAL | $1,491 | $N/A | $N/A | $N/A |
| Total Assets | $131,136 | $0 | $0 | $0 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,580 | 0 | 0 | 0 |
| TOTAL | $4,342 | $0 | $0 | $0 |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,342 | $0 | $0 | $0 |
| Shareholders' Equity | ||||
| Retained earnings | -34,147 | 0 | 0 | 0 |
| Other shareholders' equity | 160,214 | 0 | 0 | 0 |
| TOTAL | $126,794 | $0 | $0 | $0 |
| Total Liabilities And Equity | $131,136 | $0 | $0 | $0 |